Increased caspase-3 activity in refractory anemias: lack of evidence for Fas pathway implication 
TO THE EDITOR
The myelodysplastic syndromes (MDS) are characterized by ineffective hematopoiesis, peripheral blood cytopenias and abnormal growth of marrow committed progenitor cells. In line with the apparent contradiction between a frequently increased marrow cellularity and peripheral cytopenias, it has been hypothesized that the functional bone marrow failure is due to premature intramedullary cell death by apoptosis. We recently described an increased activation of cysteine proteases (caspases), particularly the major effector protein of the programmed cell death caspase-3, which was readily inhibited by a specific caspase inhibitor Ac-DEVD-CHO. This was especially observed in refractory anemia (RA) and RA with ringed sideroblasts (RARS), Caspase activity expressed in pmoles/min/mg of proteins is assessed in the S100 cytosolic fraction extract of bone marrow mononuclear cells (BMMNC).
Figure 1
Caspase protease activities (pmoles/min/mg of proteins) assessed by a fluorometric study with specific fluorogenic substrates Ac-DEVD-AMC (caspase-3-like activity) (a) and Z-IETD-AFC (caspase-8 activity) (b) in the S100 cytosolic fraction of BMMNC, after Ficoll (T0) and 24 h culture (T24h). Each number reported corresponds to the same MDS sample. plasmic domain of Fas, the adaptor molecule FADD/MORT-1, and procaspase-8. Activated caspase-8 subsequently cleaves caspase-3 either directly or through the activation of Bid, a pro-apoptotic member of the Bcl-2 family which in turn releases mitochondrial cytochrome-c. 4 The present study investigated the functional role of the Fas/Fas-L pathway in the increased apoptosis of hematopoietic cells in a series of nine RA and three RARS samples according to the FAB classification (Table 1) . We assessed caspase-3 and -8 activities and Bid expression in bone marrow mononuclear cells (BMMNC) immediately after separation (T0) and/or after 24 h culture (T24h) in RPMI medium supplemented with 10% of fetal calf serum. In some experiments (five RA samples) Fas receptor was blocked by addition of an antagonistic anti-Fas antibody (clone ZB4, 500 ng/ml) into the culture.
The cytosolic fraction (S100) was isolated as described elsewhere. 5 Caspase activities were then assessed by fluorimetric assay with specific fluorogenic substrates Ac-DEVD-AMC (caspase-3 activity) and Z-IETD-AFC (caspase-8 activity). Western blot analysis of Bid (cytosolic form, 22 kDa) expression was performed as described elsewhere. 1 The films were scanned and quantified using the NIH image 1.61 software.
A positive control of caspase-8 activation was performed concommitently in a model of U937 cells induced into apoptosis by a 12 h incubation with an anti-Fas agonistic antibody (50 ng/ml CH-11 plus
Figure 2
Representative Western blot analysis of Bid expression (22 kDa) in cytosolic (S100) fraction extracts of BMMNC, in three conditions: (a) after Ficoll (T0), (b) after 24 h culture, (c) after 24 h culture with ZB4 (500 ng/ml). 0.8 g/ml cycloheximide), with or without preincubation with ZB4 (500 ng/ml). In this model, ZB4 inhibited more than 80% of CH-11-induced caspase-8 activity (data not show).
Nine MDS cases were assessed for caspase-3 activity before and after culture. The mean activity was significantly higher after culture (171 ± 96 pmoles/min/mg of proteins vs 99 ± 55 at T0, P = 0.02 using Student's t-paired test) (Figure 1a ). Caspase-8 activity was available in eight cases at timepoints T0 and T24h. There was no significant difference; respectively 88 ± 55 pmoles/min/mg of proteins vs 75 ± 47 (P = 0.3) (Figure 1b) . There was no correlation either between caspase-3 and caspase-8 activities. For instance, case No. 2 exhibited at T24h a very high caspase-3 activity, but a low caspase-8 activity.
Finally, the effects of Fas blocking by ZB4 were evaluated in five samples after a 24 h culture. Caspase-8 and caspase-3 activities were not modified ( Table 2 ). Mean caspase-3 and -8 activities were respectively: 220 pmoles/min/mg of proteins and 54 without ZB4, vs 210 and 57 in the presence of ZB4. Bid cytosolic expression (22 kDa) with or without ZB4 was also assessed. The expression of Bid was not significantly modulated (blots are shown in Figure 2 ). Only case No. 8 with ZB4 preincubation showed a high expression of Bid as compared to T0 or T24h (two-fold higher signal), but without correlation with levels of caspase-8 and -3 activities.
We confirm in this paper our initial results regarding caspase-3 activation in MDS. We used here cytosolic protein fractions instead of total protein extracts, with a better (two-fold) sensitivity. The mechanisms of caspase-3 activation remain to be investigated. An upregulation of Fas and Fas-L expression on BMMNC and CD34 + cells of MDS has been reported. 2, 3 However, data regarding the functional implication of Fas system are contradictory. In the study by Gersuk et al, 3 the expression of Fas-L on bone marrow cells was lower in RA than in other MDS categories. Activation of the Fas system by an agonist anti-fas MoAb (CH-11) showed that the Fas protein was not always functional. 2 Recently, Hellstrom-Lindberg et al 6 demonstrated that Fas-blocking fragments had comparable effects (proliferation, clonogenic growth, apoptosis) on RARS and normal bone marrow cells. Thus, if Fas protein is functional in RARS its role seems to be equivalent to that observed in normal hematopoiesis.
In our study we show after 24 h culture an increased caspase-3 activity in RA and RARS samples which is not related to the activation of the Fas pathway. Indeed, ZB4 molecule did not modify caspase-8 and -3 activities or Bid expression in RA samples. Taken together, our findings do not support the implication of the Fas pathway at least in this in vitro condition. The mitochondrial pathway is an alternative apoptotic mechanism. This mechanism is already suspected in RARS which are characterized by primary mitochondrial defects possibly affecting the cytochrome-c release. An impairment of mitochondrial energy production with defective heme synthesis or iron deposition is likely to play a role in the induction of apoptosis. 7 Our study suggests that mitochondrial anomalies should also be investigated in RA.
Moreover, we have studied the proteolytic activity (caspase-3 or -8 activity) in the whole BMMNC population. Of note, the four cases with the lowest percentage of erythroblasts (<20%) exibited the highest caspase-3 and -8 activities (cases Nos 2, 3, 5 and 10) ( Table  1) . We are now investigating the mechanisms of caspase activation in different (ie erythroid and myeloid) cell fractions. D Boudard 
